Dr. Roger Kenji Long, MD

Dr. Long practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Long's NPI, 1285641449, was assigned on August 1, 2006. Dr. Long graduated from Vanderbilt University School Of Medicine in 1999. Dr. Long holds California license A74233.

Dr. Long's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Long's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Long is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Long to 4 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Long practices, 5 sites in all. Vendor and product names are available with a free account.

Pediatric endocrinology is Dr. Long's primary specialty in the NPI Registry, under taxonomy code 2080P0205X. Dr. Long is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Long is licensed in California.

Dmand AI lists chronic diabetes and diabetic emergency among the conditions Dr. Long treats.

CMS data shows 155 Medicare services from Dr. Long across 5 procedure codes in 2024, for 118 Medicare patients. Medicare paid $14,668 for them. Every service was in an office.

CMS counts 118 Medicare patients who saw Dr. Long in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have osteoporosis, and 68% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Long's median patient age at 69, with 73% women.

In 2024, Dr. Long wrote 336 Medicare Part D claims for 60 patients. 58% of them were for generic drugs. CMS names the drug for 269 of them, across 6 drugs with 11 or more claims each, at $620,594 in total drug cost. In 2023, CMS named 256 claims across 6 drugs.

Dr. Long accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Long as offering telehealth.

Dmand AI links 15 papers to Dr. Long, published from 2014 to 2022. 2017 was the busiest year, with 4. The most frequent topics are Signal Transduction, Bone and Bones and Insulin-Like Growth Factor I. Dr. Long has published most often in J Bone Miner Res. Dr. Long's most frequent co-authors are Daniel David Bikle, MD, Anne Louise Schafer, MD and Nancy E. Lane, MD.

CMS Open Payments shows 32 general payments to Dr. Long from 4 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 58% of the total. Alexion Pharmaceuticals, Inc. paid the most, $16,864.

Dmand AI lists 1 award for Dr. Long, most recently CMS Stage 1 EHR in 2011.

Dr. Long graduated from Vanderbilt University School Of Medicine in 1999.

Dr. Long is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.